Pharmacogenetics of obsessive-compulsive disorders. - Wikidata - wikimedia - TriplyDB

Pharmacogenetics of obsessive-compulsive disorders.

Pharmacogenetics of obsessive-compulsive disorders.

http://www.wikidata.org/entity/Q37969219

about

GABA and Glutamate Transporters in Brain Glutamate as a neurotransmitter in the healthy brain Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes Whole-genome association analysis of treatment response in obsessive-compulsive disorder.Pharmacogenomic testing for neuropsychiatric drugs: current status of drug labeling, guidelines for using genetic information, and test options.Pharmacogenetics of antidepressant treatment in obsessive-compulsive disorder: an update and implications for clinicians.Pharmacological treatment of obsessive-compulsive disorder The Glutamate-Glutamine Cycle in Epilepsy.Influence of CYP2D6 and CYP2C19 gene variants on antidepressant response in obsessive-compulsive disorder.Facilitation of serotonin signaling by SSRIs is attenuated by social isolation.Association of serotonin receptor 2a haplotypes with obsessive-compulsive disorder and its treatment response in Iranian patients: a genetic and pharmacogenetic study.

P2860

Q21090476-C2505200-3FB8-49ED-A142-07C863665171 Q34048502-F35543CA-BD86-4477-9854-470A0AA6FCDD Q35236862-3F7349DB-53A5-4D3A-A743-406CEA13E294 Q37265337-C6E880B0-471F-4DC8-94BB-614037F8CF6F Q37612442-C87C624C-460B-4A48-8B84-570BD854B545 Q38236029-DDE2085A-6DD7-4854-97D8-A357AA624D13 Q38242548-B04BA551-B7A7-4BBA-A2B7-7A07BB1ABE72 Q39019326-CBA97175-2631-457A-BA70-BFDD6385475B Q39441964-E159A748-4AFF-45A3-AC63-1FAD5895385C Q42088160-EC4BA1F4-4FB2-48CD-A938-299A2A90AC0C Q55280383-0D1A0A89-45ED-439C-AD7E-94B8FB47FCCD

P2860

Pharmacogenetics of obsessive-compulsive disorders.

http://www.wikidata.org/entity/Q37969219

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacogenetics of obsessive-compulsive disorders.

@en

Pharmacogenetics of obsessive-compulsive disorders.

@nl

type

label

Pharmacogenetics of obsessive-compulsive disorders.

@en

Pharmacogenetics of obsessive-compulsive disorders.

@nl

prefLabel

Pharmacogenetics of obsessive-compulsive disorders.

@en

Pharmacogenetics of obsessive-compulsive disorders.

@nl

P1433

Q37969219-55A33B9E-07B6-464C-B4E6-5B4BCC87202E

P1476

Q37969219-EB54AE65-7440-4D46-8D59-AA7113B7461A

P2093

Q37969219-1C49567C-425D-4193-86E5-42523A2DA46E

Q37969219-89040A11-A33E-4218-95D8-F56BC2921505

P2860

Q37969219-004740A2-651A-40D2-BE4F-8043FFE4967B

Q37969219-03ACCC93-52E5-4FB8-A543-F8F9DDA1616C

Q37969219-03E7B5D8-22FF-49D1-8DA6-F239C555B24E

Q37969219-04259AF7-0EF3-4EA6-AB85-E2F244C3EE40

Q37969219-061D0EA4-1D4E-4F9D-B407-F5313372C426

Q37969219-07C5B017-7D78-4437-A160-811BCE76FACD

Q37969219-07F0CC32-1294-4B0F-BD48-660526C9F2BC

Q37969219-080A1227-8D49-4222-BBAF-FBBAC078E2D6

Q37969219-0B2CBA3C-939B-425C-99AF-C3EA1FBFEEF4

Q37969219-0B912327-128F-412A-8F31-A01B5285F313

P304

Q37969219-F90F8F96-1264-4B1A-8A04-79D1CDA22995

P31

Q37969219-EA347664-98C1-4610-8F66-3FA037C34FAE

P356

Q37969219-2293C545-58C8-4D97-B7CB-AC017CF4E301

P433

Q37969219-FC7EC67D-7225-4A41-82F1-32A3E838E34C

P478

Q37969219-995A28E5-6A8B-4CAF-AE5D-98650E94119A

P50

Q37969219-6B8B673E-F79E-4374-86B5-59FF93ACDD05

P577

Q37969219-3A75AD5A-F9F3-44D1-9F3A-2E82120802B2

P698

Q37969219-6BF5FD31-D994-400E-9036-E632B091BC43

P921

Q37969219-BF9B20DD-AD39-4DDC-BDA7-96B475879145

P356

P1433

Pharmacogenomics

P1476

Pharmacogenetics of obsessive-compulsive disorders.

@en

P2093

Daniel J Müller

http://www.w3.org/2001/XMLSchema#string

Margaret A Richter

http://www.w3.org/2001/XMLSchema#string

P2860

Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization

Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment

The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

Neuroimaging studies of obsessive-compulsive disorder in adults and children.

Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited.

Serotonin transporter function is modulated by brain-derived neurotrophic factor (BDNF) but not nerve growth factor (NGF).

Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder.

Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.

No association between obsessive-compulsive disorder and the 5-HT(1Dbeta) receptor gene.

P304

71-81

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/PGS.11.133

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22176623

http://www.w3.org/2001/XMLSchema#string

P921

obsessive-compulsive disorder